Burdick Kenneth A 4
4 · LifeStance Health Group, Inc. · Filed Mar 10, 2025
Insider Transaction Report
Form 4
Burdick Kenneth A
Director
Transactions
- Award
Common Stock
2025-03-06+95,178→ 3,029,550 total - Tax Payment
Common Stock
2025-03-07$7.59/sh−111,430$845,754→ 3,147,690 total - Award
Common Stock
2025-03-07+423,790→ 3,571,480 total - Award
Common Stock
2025-03-07+283,172→ 3,259,120 total - Tax Payment
Common Stock
2025-03-06$7.88/sh−53,602$422,384→ 2,975,948 total - Tax Payment
Common Stock
2025-03-07$7.59/sh−166,762$1,265,724→ 3,404,718 total
Footnotes (6)
- [F1]Includes 95,178 restricted stock units ("RSUs") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
- [F3]Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 8, 2024, which vested on March 7, 2025.
- [F4]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
- [F5]Represents PSUs previously granted to the Reporting Person on February 28, 2024, which vested on March 7, 2025.
- [F6]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.